RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 3 filers reported holding RELAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $867,862 | -40.7% | 103,194 | -11.4% | 0.03% | -40.0% |
| Q2 2023 | $1,463,328 | +6.0% | 116,507 | +26.1% | 0.06% | -24.7% |
| Q4 2022 | $1,380,650 | +319.7% | 92,413 | +763.7% | 0.07% | +247.6% |
| Q4 2021 | $329,000 | -85.1% | 10,700 | -84.7% | 0.02% | -86.9% |
| Q3 2021 | $2,210,000 | +233.3% | 70,100 | +286.8% | 0.16% | +150.0% |
| Q2 2021 | $663,000 | – | 18,125 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,139,380 | $73,958,000 | 8.86% |
| Darwin Global Management, Ltd. | 782,471 | $27,050,000 | 5.30% |
| EcoR1 Capital, LLC | 3,429,363 | $118,553,000 | 5.26% |
| Foresite Capital Management V, LLC | 400,000 | $13,828,000 | 4.06% |
| Grace Capital | 183,112 | $6,330,000 | 4.03% |
| BVF INC/IL | 2,873,147 | $99,325,000 | 3.72% |
| Casdin Capital, LLC | 3,375,058 | $116,676,000 | 3.48% |
| Fernwood Investment Management, LLC | 185,063 | $6,398,000 | 2.35% |
| Alphabet Inc. | 1,568,486 | $54,222,000 | 2.19% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $964,675,000 | 1.67% |